Article Information
History
- February 18, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Robin J. G. Hartman1,*,
- Ernest Diez Benavente1,*,
- Lotte Slenders2,
- Arjan Boltjes2,
- Barend M. Mol3,
- Gert J. de Borst3,
- Dominique P. V. de Kleijn3,
- Koen H. M. Prange4,
- Menno P. J. de Winther4,
- Johan Kuiper4,
- Mete Civelek5,6,
- Sander W. van der Laan2,
- Steve Horvath7,8,9,
- Charlotte Onland-Moret10,
- Michal Mokry2,
- Gerard Pasterkamp2,* and
- Hester M. den Ruijter1,*,†
- 1Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 2Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 3Department of Vascular Surgery, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
- 4Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
- 5Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA
- 6Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA
- 7Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
- 8Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA
- 9Altos Labs, Cambridge Institute of Science, Cambridge, UK
- 10Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3508 GA Utrecht, Utrecht University, Utrecht, The Netherlands
- ↵†Corresponding author Corresponding author:
Hester M. den Ruijter, PhD, Division of Heart & Lungs, Department of Cardiology, Laboratory of Experimental Cardiology, H.M.denruijter-2{at}umcutrecht.nl
↵* These authors contributed equally
Posted February 18, 2023.
Atherosclerotic plaque epigenetic age acceleration is characterized by mesenchymal reprogramming and poor prognosis
